Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 4
2006 2
2007 7
2008 4
2009 5
2010 9
2011 8
2012 7
2013 12
2014 13
2015 5
2016 2
2017 5
2018 7
2019 4
2020 3
2021 2
2022 3
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.
Pfeiffer T, Tzannou I, Wu M, Ramos C, Sasa G, Martinez C, Lulla P, Krance RA, Scherer L, Ruderfer D, Naik S, Bocchini C, Fraser IP, Patel B, Ward D, Wang T, Heslop HE, Leen AM, Omer B. Pfeiffer T, et al. Among authors: leen am. Clin Cancer Res. 2023 Jan 17;29(2):324-330. doi: 10.1158/1078-0432.CCR-22-2415. Clin Cancer Res. 2023. PMID: 36628536 Free PMC article. Clinical Trial.
Antiviral T-cell therapy.
Leen AM, Heslop HE, Brenner MK. Leen AM, et al. Immunol Rev. 2014 Mar;258(1):12-29. doi: 10.1111/imr.12138. Immunol Rev. 2014. PMID: 24517423 Free PMC article. Review.
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, Carrum G, Sasa G, Lulla P, Watanabe A, Kuvalekar M, Gee AP, Wu MF, Liu H, Grilley BJ, Krance RA, Gottschalk S, Brenner MK, Rooney CM, Heslop HE, Leen AM, Omer B. Tzannou I, et al. Among authors: leen am. J Clin Oncol. 2017 Nov 1;35(31):3547-3557. doi: 10.1200/JCO.2017.73.0655. Epub 2017 Aug 7. J Clin Oncol. 2017. PMID: 28783452 Free PMC article. Clinical Trial.
Engineered T cells for cancer treatment.
Anurathapan U, Leen AM, Brenner MK, Vera JF. Anurathapan U, et al. Among authors: leen am. Cytotherapy. 2014 Jun;16(6):713-33. doi: 10.1016/j.jcyt.2013.10.002. Epub 2013 Nov 13. Cytotherapy. 2014. PMID: 24239105 Free PMC article. Review.
T-cell therapy for viral infections.
Heslop HE, Leen AM. Heslop HE, et al. Among authors: leen am. Hematology Am Soc Hematol Educ Program. 2013;2013:342-7. doi: 10.1182/asheducation-2013.1.342. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319202 Review.
T lymphocytes targeting native receptors.
Rooney CM, Leen AM, Vera JF, Heslop HE. Rooney CM, et al. Among authors: leen am. Immunol Rev. 2014 Jan;257(1):39-55. doi: 10.1111/imr.12133. Immunol Rev. 2014. PMID: 24329788 Free PMC article. Review.
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer.
Hoyos V, Vasileiou S, Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, Lulla S, Robertson C, Foreman C, Wang T, Bulsara S, Lapteva N, Grilley B, Ellis M, Osborne CK, Coscio A, Nangia J, Heslop HE, Rooney CM, Vera JF, Lulla P, Rimawi M, Leen AM. Hoyos V, et al. Among authors: leen am. Ther Adv Med Oncol. 2022 Jul 15;14:17588359221107113. doi: 10.1177/17588359221107113. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35860837 Free PMC article.
Is cancer gene therapy an empty suit?
Brenner MK, Gottschalk S, Leen AM, Vera JF. Brenner MK, et al. Among authors: leen am. Lancet Oncol. 2013 Oct;14(11):e447-e456. doi: 10.1016/S1470-2045(13)70173-6. Lancet Oncol. 2013. PMID: 24079872 Free PMC article. Review.
106 results